Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

12 treatments under study, led by Deproteinized Bovine Bone

Research Leaders

11 sponsors active, led by Cairo University

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (5)
Phase 1/2 (1)
Phase 2 (1)
Phase 3 (1)

Trial Status

Completed4
Unknown2
Recruiting1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Deproteinized Bovine Bone1
  • Granules Of Deproteinized Bovine Bone Biooss1
  • Bone Marrow Stem Cells Concentrate Platelet Rich Fibrin Bone Graft1
  • Low Level Laser Treatment1
  • Guided Bone Regeneration1

Active Sponsors

  • Cairo University3
  • Citospin1
  • Sanidad de Castilla y León1
  • Centro en Red de Medicina Regenerativa de Castilla y Leon1
  • Geistlich Pharma AG1

Top Investigators

Related Conditions

  • Orbital Neoplasms1
  • Zygomatic Fractures1
  • Facial Deformity1
  • Bone Loss Of Substance1
  • Mandibular Cyst1

Activity Timeline